Pulmovant, Inc.
Clinical trials sponsored by Pulmovant, Inc., explained in plain language.
-
New inhaled drug shows promise for lung scarring and heart strain
Disease control OngoingThis study tests an inhaled medicine called mosliciguat for people with high blood pressure in the lungs caused by scarring lung disease. About 135 adults will receive either the drug or a placebo for 16 weeks. The goal is to see if the drug improves blood flow in the lungs and w…
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 26, 2026 04:42 UTC
-
Healthy men help scientists track new Drug's journey through the body
Knowledge-focused OngoingThis early-stage study looks at how healthy adult men absorb, process, and eliminate the experimental drug mosliciguat. Eight participants will receive the drug by inhalation, injection, and mouth to track its path. The goal is to understand the drug's behavior in the body, not t…
Phase: PHASE1 • Sponsor: Pulmovant, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC